Mercado Europeu de Fabrico de Células Estaminais – Tendências da Indústria e Previsão para 2028

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Medical Devices Europe Stem Cell Manufacturing Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Europeu de Fabrico de Células Estaminais – Tendências da Indústria e Previsão para 2028

  • Medical Devices
  • Publish Reports
  • Aug 2021
  • Europe
  • 350 Páginas
  • Número de tabelas: 186
  • Número de figuras: 36
Comprar agora Comprar agora

Europe Stem Cell Manufacturing Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
 2021 –2028
Diagram Tamanho do mercado (ano base )
 USD 11,076.78 Million
Diagram Tamanho do mercado ( Ano de previsão)
 USD 23,505.08 Million
Diagram CAGR
 %
Diagram Principais participantes do mercado
  • Manequim1
  • Manequim2
  • Manequim3
  • Manequim4
  • Manequim5
Pedido de desbloqueio

>Mercado europeu de fabrico de células estaminais, por produtos (linhas de células estaminais, instrumentos, consumíveis e kits), aplicação (aplicações de investigação, aplicações clínicas, bancos de células e tecidos e outros), utilizador final (empresas de biotecnologia e farmacêuticas, institutos de investigação e institutos académicos, Bancos de células e bancos de tecidos, centros hospitalares e cirúrgicos e outros), canal de distribuição (vendas diretas e distribuidor terceirizado), país (Alemanha, França, Reino Unido, Itália, Espanha, Rússia , Bélgica, Turquia, Suíça, Países Baixos e resto da Europa) Tendências e previsões da indústria para 2028.   

Mercado Europeu de Fabrico de Células-TroncoAnálise de Mercado e Insights: Mercado Europeu de Fabrico de Células Estaminais

Espera-se que o mercado europeu de fabrico de células estaminais ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 10,1% no período de previsão de 2021 a 2028 e prevê-se que atinja os 23.505,08 milhões de USD até 2028, contra os 11.076,78 milhões de dólares em 2020. A crescente prevalência do cancro e do transplante de células estaminais, o crescimento de novos avanços tecnológicos para o transplante de células estaminais serão provavelmente os principais impulsionadores que impulsionam a procura do mercado no período de previsão.

As células estaminais são a matéria-prima do corpo que se pode diferenciar numa variedade de células. Significa células a partir das quais são geradas todas as outras células com funções especializadas. As terapias com células estaminais são definidas como tratamento para condições médicas que envolvem a utilização de qualquer tipo de células estaminais humanas , incluindo células estaminais embrionárias, células estaminais adultas para terapias alogénicas e autólogas.

O advento da investigação com células estaminais revelou o potencial terapêutico das células estaminais e derivados . O fabrico bem-sucedido de células estaminais e seus derivados está a causar um impacto positivo na área da saúde. Estes produtos de células estaminais são utilizados para restaurar a função de tecidos e órgãos danificados e para desenvolver terapias celulares baseadas em células estaminais para o tratamento de cancro, distúrbios hematológicos, distúrbios genéticos , doenças autoimunes e inflamatórias.

O aumento da investigação e desenvolvimento por parte dos principais intervenientes da indústria para o desenvolvimento de produtos inovadores, o apoio governamental e a crescente adopção de células estaminais estão a impulsionar o crescimento do mercado. As metodologias avançadas presentes na área estão também a impulsionar o crescimento do mercado global de fabrico de células estaminais. No entanto, o elevado custo das terapias e a disponibilidade de alternativas para o tratamento do tumor podem restringir o mercado. A presença de um grande número de produtos em pipelines, juntamente com iniciativas estratégicas tomadas pelos participantes do mercado, estão a funcionar como uma oportunidade para o mercado. A falta de profissionais qualificados pode ser um desafio para o mercado.

O relatório global do mercado de fabrico de células estaminais fornece detalhes de quota de mercado, novos desenvolvimentos e impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para obter um Analyst Brief. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.

Mercado Europeu de Fabrico de Células-TroncoÂmbito e tamanho do mercado de fabrico de células estaminais

O mercado de fabrico de células estaminais está categorizado em quatro segmentos notáveis ​​que se baseiam em produtos, aplicação, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

  • Com base nos produtos, o mercado de fabrico de células estaminais está segmentado em linhas de células estaminais, instrumentos, consumíveis e kits. Em 2021, prevê-se que o segmento dos consumíveis e kits domine o mercado devido à compra frequente de consumíveis, ao aumento da investigação com células estaminais e ao aumento da procura de terapias com células estaminais.
  • Com base na aplicação, o mercado de fabrico de células está segmentado em aplicações de investigação, aplicações clínicas, bancos de células e tecidos e outros. Em 2021, prevê-se que o segmento das aplicações de investigação domine o mercado devido ao crescente foco na investigação de citologia e fisiopatologia das células estaminais e ao crescente financiamento público-privado para apoiar o desenvolvimento e comercialização de produtos com células estaminais.
  • Com base no utilizador final, o mercado de fabrico de células estaminais está segmentado em empresas de biotecnologia e farmacêuticas, institutos de investigação e institutos académicos, bancos de células e bancos de tecidos, hospitais e centros cirúrgicos e outros. Em 2021, prevê-se que o segmento das empresas farmacêuticas e de biotecnologia domine o mercado devido à crescente ênfase em iniciativas estratégicas (como aquisições, parcerias e colaborações) por parte das empresas farmacêuticas e de biotecnologia para expandir as suas capacidades na investigação com células estaminais.
  • Com base no canal de distribuição, o mercado de fabrico de células estaminais está segmentado em vendas diretas e distribuidores externos. Em 2021, prevê-se que o segmento de vendas diretas domine o mercado devido ao grande número de players no mercado.

Análise a nível de país do mercado europeu de fabrico de células estaminais

O mercado de fabrico de células estaminais é analisado e as informações sobre o tamanho do mercado são fornecidas por produtos, aplicação, utilizador final e canal de distribuição.

Os países abrangidos no relatório do Mercado de Fabrico de Células Estaminais da América do Norte são a Alemanha, França, Reino Unido, Itália, Espanha, Rússia, Bélgica, Turquia, Suíça, Países Baixos e Resto da Europa.

Germany is dominating the global stem cell manufacturing market in the Europe region due to presence of untapped opportunities in Germany for stem cell based products and increased prevalence cases of cancer in Germany.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Stem Cell Manufacturing Market  

The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.

Competitive Landscape and Europe Stem Cell Manufacturing Market Share Analysis

Europe stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.

The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.

The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.

For instance,

  • In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
  • Em junho de 2021, a Catalent Inc. anunciou que adquiriu a RheinCell Therapeuics, que é fabricante de células estaminais pluripotentes induzidas por humanos. Isto ajudará a empresa a desenvolver o processo de desenvolvimento de terapia celular personalizado existente.
  • Em junho de 2021, a Bio-Techne anunciou que tinha melhorado a sua capacidade de engenharia genética e de fabrico de terapia celular e genética. Isto ajudará a empresa a expandir ainda mais o seu negócio.

A colaboração, as joint ventures e outras estratégias do player de mercado estão a melhorar o mercado da empresa no mercado de fabrico de células estaminais, o que também oferece o benefício para a organização melhorar a sua oferta para o mercado de fabrico de células estaminais.

 

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe stem cell manufacturing market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCTs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. EUROPE STEM CELL MANUFACTURING MARKET: REGULATIONS
    1. REGULATORY FRAMEWORK IN THE UNITED STATES
    2. REGULATORY FRAMEWORK IN EUROPE
    3. REGULATORY FRAMEWORK IN INDIA
    4. REGULATORY FRAMEWORK IN JAPAN
  6. pestel analysis
  7. porters five forces
  8. Market Overview
    1. Drivers
      1. INCREASING PREVaLENCE OF CANCEr
      2. INCREASE INVESTMENT IN R & D
      3. increasing adoption of stem cell therapy
      4. growing biotechnology sector, along with rising healthcare expenditure
    2. restrainTs
      1. high cost associated with therapies
      2. availability of alternatives for tumor treatment
      3. adverse effects of stem cell transplant
    3. opportunities
      1. presence of pipeline products
      2. strategic initiatives by market players
      3. rising healthcare infrastructure by various countries
      4. increasing interest for personalized medicine
    4. challenges
      1. LACK OF skilled professionals
      2. STRINGENT REGULATIONs
  9. IMPACT OF COVID-19 ON EUROPE STEM CELL MANUFACTURING MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
    5. CONCLUSION
  10. Europe stem cell manufacturing market, By products
    1. overview
    2. consumables & kits
      1. Culture Media
      2. differentiation kits
      3. stem cell antibody arrays
      4. identification kits
      5. stem cell antibody panels
      6. stem cell primer pair panels
      7. Cytokine panels for hematopoietic stem cell expansion
      8. lineage depletion antibodies & kits
      9. others
    3. stem cell lines
      1. human cell systems
        1. INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
        2. MESENCHYMAL STEM CELLS
        3. PRIMARY HUMAN CELLS
          1. FIBROBLAST
          2. EPITHELIAL
          3. ENDOTHELIAL
        4. HEMATOPOIETIC STEM CELLS
        5. NEURAL STEM CELLS
        6. CARDIAC STEM CELLS
        7. PANCREATIC STEM CELLS
        8. OTHERS
      2. rodent cell systems
        1. PLURIPOTENT MOUSE ES CELLS
        2. MOUSE EMBRYO CULTURE
        3. PMEFS
        4. MULTIPOTENT RODENT STEM CELLS
        5. MESENCHYMAL STEM CELLS
        6. NEURAL STEM CELLS
        7. OTHERS
    4. instruments
      1. BIOREACTORS & INCUBATORS
      2. cell sorters
      3. others
  11. Europe STEM CELL MANUFACTURING market, By APPLICATION
    1. overview
    2. research applications
      1. lIFE SCIENCE RESEARCH
      2. drug discovery AND development
    3. clinical applications
      1. ALLOGENIC STEM CELL THERAPY
        1. SURGERIES
        2. MUSCULOSKELETAL DISORDERS
        3. WOUNDS AND INJURIES
        4. ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
        5. OTHERS
      2. AUTOLOGOUS STEM CELL THERAPY
        1. WOUNDS & INJURIES
        2. CARDIOVASCULAR DISEASES
        3. GASTROINTESTINAL DISEASES
        4. OTHERS
    4. cell & tissue banking
    5. others
  12. Europe STEM CELL MANUFACTURING market, By END USER
    1. overview
    2. biotechnology & pharmaceutical companies
    3. RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
    4. cell banks & tissue banks
    5. hospitals & surgical centers
    6. others
  13. Europe stem cell manufacturing market, By distribution channel
    1. overview
    2. DIRECT sales
    3. third party distributors
  14. EUROPE stem cell manufacturing MARKET, BY REGION
    1. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Netherlands
      6. Switzerland
      7. Spain
      8. Russia
      9. Belgium
      10. Turkey
      11. Rest of Europe
  15. EUROPE Stem Cell Manufacturing Market: COMPANY landscape
    1. company share analysis: Europe
  16. swot analysis
  17. company profile
    1. THERMO FISHER SCIENTIFIC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. takeda pharmaceutical company limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Merck kgaa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. AMERICAN cryosystem corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. ANTEROGEN.CO.,LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. astellas pharma inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    8. Bio-TECHNE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. catalent, inc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. daiichi sankyo company, limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. fujifilm cellular dynamics, inc.
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. Product Portfolio
      4. Recent Developments
    12. mesoblast ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. organogenesis inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. promocell gmbh
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    15. reprocell inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. sartorius ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. stemcell technologies inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    18. vericel corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. viacyte, inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    20. vistagen therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  18. questionnaire
  19. related reports

Lista de Tabela

TABLE 1 Below provided are the alternatives for cancer treatment:

TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 3 EUROPE stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 4 Europe consumables & kits in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 5 EUROPE consumables & kits in stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 6 Europe stem cell lines in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe stem cell lines in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 8 Europe human cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 9 Europe primary human cells in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 10 Europe rodent cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 11 Europe instruments in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe instruments in stem cell manufacturing Market, By PRODUCT, 2019-2028 (USD Million)

TABLE 13 Europe stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 14 Europe research applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 15 Europe research applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 16 Europe clinical applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 17 Europe clinical applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 18 Europe allogenic stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 19 Europe autologous stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 20 Europe cell & tissue banking in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 21 Europe others in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 22 Europe stem cell manufacturing Market, By end user, 2019-2028 (USD Million)

TABLE 23 Europe biotechnology & pharmaceuticaL COMPANIES IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 24 Europe research institutes and academic institutes IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 25 Europe cell banks & tissue banks IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 26 Europe hospitals & surgical centers IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 27 Europe others IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 28 Europe stem cell manufacturing Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 29 Europe Direct sales in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 30 Europe third party distributors in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 31 Europe Stem Cell Manufacturing Market, By country, 2019-2028 (USD Million)

TABLE 32 EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 33 Europe Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 34 Europe Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 35 Europe Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 36 Europe Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 37 Europe Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 38 Europe Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 39 Europe Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 40 Europe Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 41 Europe Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 42 Europe Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 43 Europe Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 44 Europe Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 45 Europe Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 46 GERMANY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 47 Germany Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 48 Germany Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 49 Germany Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 50 Germany Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 51 Germany Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 52 Germany Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 53 Germany Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 54 Germany Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 55 Germany Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 56 Germany Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 57 Germany Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 58 Germany Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 59 Germany Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 FRANCE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 61 France Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 62 France Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 63 France Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 64 France Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 65 France Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 66 France Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 67 France Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 68 France Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 69 France Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 70 France Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 71 France Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 72 France Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 73 France Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 U.K. STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 75 U.K. Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 76 U.K. Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 77 U.K. Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 78 U.K. Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 79 U.K. Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 80 U.K. Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 81 U.K. Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 82 U.K. Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 83 U.K. Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 84 U.K. Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 85 U.K. Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 86 U.K. Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 87 U.K. Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 88 ITALY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 89 Italy Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 90 Italy Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 91 Italy Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 92 Italy Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 93 Italy Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 94 Italy Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 95 Italy Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 96 Italy Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 97 Italy Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 98 Italy Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 99 Italy Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 100 Italy Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 101 Italy Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 NETHERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 103 Netherland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 104 Netherland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 105 Netherland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 106 Netherland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 107 Netherland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 108 Netherland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 109 Netherland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 110 Netherland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 111 Netherland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 112 Netherland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 113 Netherland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 114 Netherland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 115 Netherland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 116 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 117 Switzerland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 118 Switzerland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 119 Switzerland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 120 Switzerland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 121 Switzerland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 122 Switzerland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 123 Switzerland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 124 Switzerland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 125 Switzerland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 126 Switzerland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 127 Switzerland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 128 Switzerland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 129 Switzerland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 SPAIN STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 131 Spain Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 132 Spain Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 133 Spain Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 134 Spain Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 135 Spain Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 136 Spainstruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 137 Spain Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 138 Spain Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 139 Spain Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 140 Spain Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 141 Spain Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 142 Spain Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 143 Spain Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 144 RUSSIA STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 145 Russia Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 146 Russia Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 147 Russia Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 148 Russia Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 149 Russia Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 150 Russia Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 151 Russia Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 152 Russia Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 153 Russia Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 154 Russia Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 155 Russia Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 156 Russia Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 157 Russia Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 158 BELGIUM STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 159 Belgium Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 160 Belgium Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 161 Belgium Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 162 Belgium Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 163 Belgium Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 164 Belgium Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 165 Belgium Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 166 Belgium Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 167 Belgium Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 168 Belgium Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 169 Belgium Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 170 Belgium Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 171 Belgium Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 172 TURKEY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 173 Turkey Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 174 Turkey Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 175 Turkey Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 176 Turkey Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 177 Turkey Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 178 Turkey Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 179 Turkey Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 180 Turkey Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 181 Turkey Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 182 Turkey Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 183 Turkey Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 184 Turkey Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 185 Turkey Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 REST OF EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

Lista de Figura

FIGURE 1 Europe stem cell manufacturing market: segmentation

FIGURE 2 Europe stem cell manufacturing market: data triangulation

FIGURE 3 Europe stem cell manufacturing market: DROC ANALYSIS

FIGURE 4 Europe stem cell manufacturing market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe stem cell manufacturing market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe stem cell manufacturing market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe stem cell manufacturing market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE stem cell manufacturing MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe stem cell manufacturing market: vendor share analysis

FIGURE 10 Europe stem cell manufacturing market: SEGMENTATION

FIGURE 11 increasing adoption of stem cell therapy is expected to drive THE Europe stem cell manufacturing market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 consumables & kits segment is expected to account for the largest share of the Europe stem cell manufacturing market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTs, OPPORTUNITIES AND CHALLENGES OF EUROPE stem cell manufacturing MARKET

FIGURE 14 New Cancer Cases Worldwide in 2018

FIGURE 15 EUROPE stem cell manufacturing MARKET, By products, 2020

FIGURE 16 EUROPE stem cell manufacturing MARKET: BY products, 2021-2028 (USD million )

FIGURE 17 EUROPE stem cell manufacturing MARKET: BY products, CAGR (2021-2028)

FIGURE 18 EUROPE stem cell manufacturing MARKET: BY products, LIFELINE CURVE

FIGURE 19 EUROPE stem cell manufacturing MARKET, By application, 2020

FIGURE 20 EUROPE stem cell manufacturing MARKET: BY application, 2021-2028 (USD million )

FIGURE 21 EUROPE stem cell manufacturing MARKET: BY application, CAGR (2021-2028)

FIGURE 22 EUROPE stem cell manufacturing MARKET: BY application, LIFELINE CURVE

FIGURE 23 EUROPE stem cell manufacturing MARKET, By end user, 2020

FIGURE 24 EUROPE stem cell manufacturing MARKET: BY end user, 2021-2028 (USD million )

FIGURE 25 EUROPE stem cell manufacturing MARKET: BY end user, CAGR (2021-2028)

FIGURE 26 EUROPE stem cell manufacturing MARKET: BY end user, LIFELINE CURVE

FIGURE 27 EUROPE stem cell manufacturing MARKET, By distribution channel, 2020

FIGURE 28 EUROPE stem cell manufacturing MARKET: BY distribution channel, 2021-2028 (USD million )

FIGURE 29 EUROPE stem cell manufacturing MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 30 EUROPE stem cell manufacturing MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 31 EUROPE Stem Cell Manufacturing Market: SNAPSHOT (2020)

FIGURE 32 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020)

FIGURE 33 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2021 & 2028)

FIGURE 34 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020 & 2028)

FIGURE 35 EUROPE STEM CELL MANUFACTURING Market: BY Products (2021-2028)

FIGURE 36 Europe Stem Cell Manufacturing Market: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on , By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe ) Industry Trends and Forecast to 2028.    .
The Europe Stem Cell Manufacturing Market size was valued at USD 11076.78 USD Million in 2020.
The Europe Stem Cell Manufacturing Market is projected to grow at a CAGR of 10.1% during the forecast period of 2021 to 2028.

Navegue pelas páginas relacionadas

Banner